# Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH

> **NCT01726049** · PHASE3 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 52 (actual)

## Conditions studied

- Heart Failure, Diastolic
- Pulmonary Hypertension

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01726049
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01726049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01726049, "Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT01726049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*